-
FROM EVIDENCE TO APPRAISAL: BEST-PRACTICE CONSIDERATIONS FOR EXTERNAL CONTROL ARMS BASED ON CANADIAN REGULATORY AND HTA REVIEWS
Mar 18, 2026, 21:38 PM -
PROSPECTIVE ASSESSMENT OF OPERATIONAL EFFICIENCY AND QUALITY PARAMETERS OF BLOOD UNITS PROCESSED BY MANUAL VERSUS FULLY AUTOMATED WHOLE BLOOD SYSTEMS IN A REGIONAL ARGENTINE BLOOD BANK
Mar 18, 2026, 21:38 PM -
COST PER MONTH OF PROGRESSION FREE SURVIVAL ANALYSIS OF THE CURRENTLY AVAILABLE TREATMENTS FOR PATIENTS WITH REFRACTORY/ RELAPSED MANTLE CELL LYMPHOMA IN THE BRAZILIAN HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFICACY AND SAFETY OF LUMATEPERONE AND OTHER ATYPICAL ANTIPSYCHOTICS APPROVED AS ADJUNCTIVE THERAPY FOR MAJOR DEPRESSIVE DISORDER: A NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC AND PROGNOSTIC VALUE OF HIGH-SENSITIVITY CARDIAC TROPONIN I IN EMERGENCY DEPARTMENT CHEST PAIN TRIAGE
Mar 18, 2026, 21:38 PM -
IMPLEMENTING PERSONALIZED ENDPOINTS TO SUPPORT REGULATORY AND REIMBURSEMENT DECISION-MAKING: A CASE OF GOAL ATTAINMENT SCALING (GAS) IN ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
A CROSS-SECTIONAL SURVEY ON CRINECERFONT AND QUALITY OF LIFE OF ADULTS WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA (CAH) IN THE UNITED STATES (US) PARTICIPATING IN CAHTALYST ADULT OPEN-LABEL EXTENSION (OLE) STUDY
Mar 18, 2026, 21:38 PM -
RACIAL AND ETHNIC DISPARITIES IN ADOPTION OF NOVEL CGRP THERAPIES FOR MIGRAINE PREVENTION: A RETROSPECTIVE COHORT STUDY USING THE KOMODO RESEARCH DATASET
Mar 18, 2026, 21:38 PM -
EVOLUTION OF USE OF RWE BY REGULATORS - CASE OF EMA
Mar 18, 2026, 21:38 PM -
ASSESSING AI AND ML TOOL PERFORMANCE IN SLRS: A TARGETED LITERATURE REVIEW AND PERFORMANCE BENCHMARK FRAMEWORK
Mar 18, 2026, 21:38 PM -
REGIONAL DISPARITIES IN OPIOID USE DISORDER AND TREATMENT ACCESS DURING PREGNANCY AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
EXPLORING GESTATIONAL WEIGHT CHANGE AMONG MOTHERS AND ASSOCIATED NEWBORN WEIGHT
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF POSTPARTUM DEPRESSION SCREENING IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD IMPACT OF ANTI-AMYLOID THERAPY IN ALZHEIMER’S DISEASE: AN INTEGRATED ANALYSIS OF 100% MEDICARE FFS CLAIMS LINKED WITH LABORATORY, ELECTRONIC MEDICAL RECORDS, AND PATIENT-REPORTED OUTCOMES MEASURES
Mar 18, 2026, 21:38 PM -
CHARACTERIZING HETEROGENEITY IN ADVERSE EVENT RISK ACROSS IMMUNOTHERAPIES IN NON-SMALL CELL LUNG CANCER USING REAL WORLD DATA
Mar 18, 2026, 21:38 PM -
COVERAGE MATTERS: INSURANCE TYPE AND ACCESS TO A USUAL SOURCE OF CARE IN MEDICAL EXPENDITURE PANEL SURVEY (2018-2023)
Mar 18, 2026, 21:38 PM -
ADOPTION AS A MISSING LINK IN HEOR: EVIDENCE MAPPING OF HEALTHCARE INNOVATION UPTAKE
Mar 18, 2026, 21:38 PM -
CHARACTERIZING ONCOLOGY PATIENT JOURNEYS AND HEALTH STATE TRANSITIONS USING A DATA-DRIVEN MARKOV TRANSITION MATRIX IN LARGE-SCALE ELECTRONIC HEALTH RECORDS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TRASTUZUMAB REZETECAN VERSUS TRASTUZUMAB DERUXTECAN FOR THE SUBSEQUENT-LINE TREATMENT OF ADVANCED HER2-MUTANT NON-SMALL-CELL LUNG CANCER: APPLICATION OF A MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
HOSPITALS' TRANSITIONS TO INCREASED OUTPATIENT CARE: IS THERE AN IMPACT ON HOSPITAL-WIDE 30-DAY READMISSIONS? AN ANALYSIS OF DATA FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES, 2014-2023
Mar 18, 2026, 21:38 PM
